Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Journal of Business News.
Press releases published on May 14, 2025

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for …

Inuvo to Present at Ladenburg Thalmann Technology Innovation Expo on May 21
LITTLE ROCK, Ark., May 14, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today that it will be participating in the Ladenburg Thalmann Innovation EXPO25, to be held on …

NETSOL Technologies Reports Third Quarter Fiscal 2025 Results
Total net revenues for Q3’25 increased by 13%, reaching $17.5 million, when compared with Q3’24. Total service revenue increased 24% in Q3’25, reaching $9.7 million, when compared with Q3,’24. Total subscription (SaaS and Cloud) and support revenues …

Brag House Continues Action to Protect Stockholders Against Potential Illegal Naked Short Selling
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the premier Gen Z engagement platform that operates at the intersection of gaming, college sports, and social interaction, today announced …

iPower Enhances SuperSuite Supply Chain Capabilities with “Made in USA” Module
RANCHO CUCAMONGA, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced the launch of a new strategic initiative under its …

Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the formation of ErnexaTX2, a wholly owned subsidiary …

FDCTech Reports Over 58% Year-over-Year Revenue Growth in Q1 2025 Driven by Strong Performance Across All Business Segments
Q1 2025 Highlights Show Continued Growth and Operating Profitability. Irvine, CA, May 14, 2025 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," PINK: FDCT), a fintech-driven firm specializing in acquiring and scaling small to mid-size legacy …

Safe & Green Holdings Corp. Provides Corporate Update
MIAMI, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Safe …

Antalpha Announces Pricing of Initial Public Offering
SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced the pricing of its initial public offering of 3,850,000 ordinary shares at a price to the public of $12.80 per ordinary share. The …

OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration
VILNIUS, Lithuania, May 14, 2025 – Leading web intelligence collection platform Oxylabs announces registration start for the year's main event. OxyCon 2025, the annual free conference uniting industry experts from all over the world, is set for October 1. …

Technip Energies nomme Marco Tiziano Barone au poste de Directeur Juridique
Technip Energies annonce la nomination de Marco Tiziano Barone en tant que Directeur Juridique et membre du Comité Exécutif du Groupe. A ce titre, il supervisera la fonction Juridique, Contrats et Conformité du Groupe. Il succède à Michael McGuinty, qui a …

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models
FREEHOLD, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that it has achieved its …

DeFi Development Corp. Reports First Quarter 2025 Financial Results and Provides Strategic Update on Solana Treasury Activity
BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DeFi Dev Corp” or the “Company”), a public-market vehicle focused on long-term Solana (“SOL”) accumulation, today announced financial results for the first quarter …

HEKA AI Mattress Named “Best Overall SleepTech Solution” in 2025 MedTech Breakthrough Awards Program
LOS ANGELES, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today …

NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference
NAARDEN, The Netherlands and MIAMI, May 14, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
-- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 -- -- Cash resources of $42.2 million as of March 31, 2025, expected to fund operations into 1Q 2026 -- …

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate …

New Episode Now Streaming on Alpha Liquid Podcast, Bittensor, Decentralizing Artificial Intelligence
Miami, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid is pleased to announce the release of Episode 5 of the Alpha Liquid Podcast, featuring an in-depth conversation between host Matthew Mousa and Brody Adreon from TAO Times. This episode dives deep …

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing …

Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
COUNCIL BLUFFS, Iowa, May 14, 2025 (GLOBE NEWSWIRE) -- Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion …